These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9873498)
21. Evidence for two binding sites on membrane-bound angiotensin-converting enzymes (ACE) for exogenous inhibitors except in testis. Brée F; Hamon G; Tillement JP Life Sci; 1992; 51(10):787-94. PubMed ID: 1325020 [TBL] [Abstract][Full Text] [Related]
22. Metabolism of [3H]benzoyl-phenylalanyl-alanyl-proline by pulmonary angiotensin converting enzyme in vivo: effects of bradykinin, SQ 14225 or acute hypoxia. Catravas JD; Gillis CN J Pharmacol Exp Ther; 1981 May; 217(2):263-70. PubMed ID: 6262480 [No Abstract] [Full Text] [Related]
23. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits. Chen X; Pitt BR; Moalli R; Gillis CN J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968 [TBL] [Abstract][Full Text] [Related]
24. Orally administered angiotensin-converting enzyme-inhibitors captopril and isoleucine-proline-proline have distinct effects on local renin-angiotensin system and corticosterone synthesis in dextran sulfate sodium-induced colitis in mice. Salmenkari H; Holappa M; Forsgard RA; Korpela R; Vapaatalo H J Physiol Pharmacol; 2017 Jun; 68(3):355-362. PubMed ID: 28820392 [TBL] [Abstract][Full Text] [Related]
25. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
26. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of [3H]captopril binding by peptide analog angiotensin converting enzyme inhibitors. Toll L; Almquist RG Biochem Biophys Res Commun; 1986 Mar; 135(3):770-7. PubMed ID: 3008745 [TBL] [Abstract][Full Text] [Related]
28. Inhibition and affinity chromatography of chicken lung angiotensin I-converting enzyme with captopril. Polanco MJ; Agapito MT; Recio JM Comp Biochem Physiol B; 1992 Jul; 102(3):527-33. PubMed ID: 1323442 [TBL] [Abstract][Full Text] [Related]
29. Cis-trans isomerization of an angiotensin I-converting enzyme inhibitor. An enzyme kinetic and nuclear magnetic resonance study. Skoglöf A; Nilsson I; Gustafsson S; Deinum J; Göthe PO Biochim Biophys Acta; 1990 Oct; 1041(1):22-30. PubMed ID: 2171661 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of angiotensin-converting enzyme by angiotensin I analogue peptide inhibitors. A kinetic study. Páldi A; Móra M; Bajusz S; Gráf L Int J Pept Protein Res; 1987 Jun; 29(6):746-54. PubMed ID: 3040610 [TBL] [Abstract][Full Text] [Related]
31. Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy. Fyhrquist F; Grönhagen-Riska C; Forslund T; Tikkanen I Am J Cardiol; 1982 Apr; 49(6):1508-10. PubMed ID: 6280480 [TBL] [Abstract][Full Text] [Related]
32. Bicyclic lactam inhibitors of angiotensin converting enzyme. Watthey JW; Gavin T; Desai M J Med Chem; 1984 Jun; 27(6):816-8. PubMed ID: 6330355 [TBL] [Abstract][Full Text] [Related]
33. Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration. Bhuyan BJ; Mugesh G Org Biomol Chem; 2011 Jul; 9(14):5185-92. PubMed ID: 21629912 [TBL] [Abstract][Full Text] [Related]
34. Increase of serum and membrane-bound angiotensin-converting enzyme by captopril (SQ 14225) treatment. Grönhagen-Riska C; Forslund T; Hortling L; Fyhrquist F Acta Med Scand Suppl; 1983; 677():101-4. PubMed ID: 6322528 [No Abstract] [Full Text] [Related]
35. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE. Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Loots MJ; Perri MG; Petrillo EW; Powell JR J Med Chem; 1988 Jan; 31(1):204-12. PubMed ID: 3336020 [TBL] [Abstract][Full Text] [Related]
36. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme. Patchett AA; Cordes EH Adv Enzymol Relat Areas Mol Biol; 1985; 57():1-84. PubMed ID: 2994404 [TBL] [Abstract][Full Text] [Related]
37. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter. Lin CJ; Akarawut W; Smith DE Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000 [TBL] [Abstract][Full Text] [Related]
38. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo. Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454 [TBL] [Abstract][Full Text] [Related]
40. The measurement of angiotensin-converting enzyme in subjects receiving captopril. Roulston JE; MacGregor GA N Engl J Med; 1980 Aug; 303(7):397. PubMed ID: 6248782 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]